DexCom upgraded at Morgan Stanley on sorting out operational issues
DexCom upgraded at Morgan Stanley on sorting out operational issues. Morgan Stanley boosted DexCom (DXCM) to overweight from equal weight saying that the maker of continuous glucose monitors has been addressing reliability issues and is exposed to an expanding total addressable market.
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.